Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Camptothecin derivatives with potent antitumor activity prepared at P&U

Oct. 16, 1997

Millennium issued U.S. patent for human melanoma gene

Oct. 16, 1997

New immunosuppressive, anticancer compounds from Kyowa Hakko

Oct. 15, 1997

Resistance modulators prepared by Byk Gulden

Oct. 15, 1997

Mayo Clinic to collaborate in developing Dendreon's dendritic cell therapy

Oct. 15, 1997

ONYX-015 combination enters phase II; U.S. patent awarded

Oct. 15, 1997

St. Jude researchers discover new role for p53

Oct. 14, 1997

Pharmacia & Upjohn discloses new distamycin derivatives

Oct. 14, 1997

Antiproliferative activity of simvastatin demonstrated against human gliomas

Oct. 13, 1997

Improved efficacy of MEN-10755 related to apoptosis?

Oct. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...